0001714899-24-000088.txt : 20240301 0001714899-24-000088.hdr.sgml : 20240301 20240301165117 ACCESSION NUMBER: 0001714899-24-000088 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 EFFECTIVENESS DATE: 20240301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-506551 FILM NUMBER: 24710869 BUSINESS ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001714899 Denali Therapeutics Inc. 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (650) 866-8548 DELAWARE None None Corporation true Ryan Watts c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Executive Officer Director Alexander O. Schuth c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Executive Officer Carole Ho c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Executive Officer Jennifer Cook c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director Jay T. Flatley c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director Erik Harris c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director Peter S. Klein c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director Steve E. Krognes c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director Vicki L. Sato c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director David P. Schenkein c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director Marc Tessier-Lavigne c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director Nancy A. Thornberry c/o Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2024-02-29 false true true false 0 499732711 499732711 0 false 11 0 0 0 false Denali Therapeutics Inc. /s/ Ryan Watts Ryan Watts President and CEO 2024-02-29